Global Prostate Cancer Diagnostics Market Research Report 2023

Publisher Name :
Date: 03-Jan-2023
No. of pages: 88
Inquire Before Buying

The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.

Highlights

The global Prostate Cancer Diagnostics market was valued at US$ 14570 million in 2022 and is anticipated to reach US$ 22860 million by 2029, witnessing a CAGR of 7.8% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Market competition is intense. Genomic Health, Abbott, OPKO, Siemens Healthcare, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. Those key players got about 4% market shares. North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49%. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnostics.

The Prostate Cancer Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Prostate Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prostate Cancer Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- OPKO

- Genomic Health

- Abbott

- Beckman Coulter

- Siemens Healthcare

- bioMeriux

- Roche

- MDx Health

- DiaSorin

- Myriad Genetics

- Ambry Genetics

Segment by Type

- Tumor Biomarker Tests

- Imaging

- Biopsy

- Other

Segment by Application

- Age Below 55

- Age 55-75

- Age Above 75

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prostate Cancer Diagnostics companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Prostate Cancer Diagnostics Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Prostate Cancer Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Diagnostics Market Perspective (2018-2029)
2.2 Prostate Cancer Diagnostics Growth Trends by Region
2.2.1 Global Prostate Cancer Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Prostate Cancer Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Prostate Cancer Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Prostate Cancer Diagnostics Market Dynamics
2.3.1 Prostate Cancer Diagnostics Industry Trends
2.3.2 Prostate Cancer Diagnostics Market Drivers
2.3.3 Prostate Cancer Diagnostics Market Challenges
2.3.4 Prostate Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Diagnostics Players by Revenue
3.1.1 Global Top Prostate Cancer Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Prostate Cancer Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Diagnostics Revenue
3.4 Global Prostate Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Prostate Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics Revenue in 2022
3.5 Prostate Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Prostate Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Diagnostics Breakdown Data by Type
4.1 Global Prostate Cancer Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Prostate Cancer Diagnostics Forecasted Market Size by Type (2024-2029)
5 Prostate Cancer Diagnostics Breakdown Data by Application
5.1 Global Prostate Cancer Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Prostate Cancer Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Prostate Cancer Diagnostics Market Size (2018-2029)
6.2 North America Prostate Cancer Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Prostate Cancer Diagnostics Market Size by Country (2018-2023)
6.4 North America Prostate Cancer Diagnostics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Diagnostics Market Size (2018-2029)
7.2 Europe Prostate Cancer Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Prostate Cancer Diagnostics Market Size by Country (2018-2023)
7.4 Europe Prostate Cancer Diagnostics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Diagnostics Market Size (2018-2029)
8.2 Asia-Pacific Prostate Cancer Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Prostate Cancer Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Prostate Cancer Diagnostics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Diagnostics Market Size (2018-2029)
9.2 Latin America Prostate Cancer Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Prostate Cancer Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Prostate Cancer Diagnostics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Diagnostics Market Size (2018-2029)
10.2 Middle East & Africa Prostate Cancer Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 OPKO
11.1.1 OPKO Company Detail
11.1.2 OPKO Business Overview
11.1.3 OPKO Prostate Cancer Diagnostics Introduction
11.1.4 OPKO Revenue in Prostate Cancer Diagnostics Business (2018-2023)
11.1.5 OPKO Recent Development
11.2 Genomic Health
11.2.1 Genomic Health Company Detail
11.2.2 Genomic Health Business Overview
11.2.3 Genomic Health Prostate Cancer Diagnostics Introduction
11.2.4 Genomic Health Revenue in Prostate Cancer Diagnostics Business (2018-2023)
11.2.5 Genomic Health Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Prostate Cancer Diagnostics Introduction
11.3.4 Abbott Revenue in Prostate Cancer Diagnostics Business (2018-2023)
11.3.5 Abbott Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Detail
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Prostate Cancer Diagnostics Introduction
11.4.4 Beckman Coulter Revenue in Prostate Cancer Diagnostics Business (2018-2023)
11.4.5 Beckman Coulter Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Detail
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Prostate Cancer Diagnostics Introduction
11.5.4 Siemens Healthcare Revenue in Prostate Cancer Diagnostics Business (2018-2023)
11.5.5 Siemens Healthcare Recent Development
11.6 bioMeriux
11.6.1 bioMeriux Company Detail
11.6.2 bioMeriux Business Overview
11.6.3 bioMeriux Prostate Cancer Diagnostics Introduction
11.6.4 bioMeriux Revenue in Prostate Cancer Diagnostics Business (2018-2023)
11.6.5 bioMeriux Recent Development
11.7 Roche
11.7.1 Roche Company Detail
11.7.2 Roche Business Overview
11.7.3 Roche Prostate Cancer Diagnostics Introduction
11.7.4 Roche Revenue in Prostate Cancer Diagnostics Business (2018-2023)
11.7.5 Roche Recent Development
11.8 MDx Health
11.8.1 MDx Health Company Detail
11.8.2 MDx Health Business Overview
11.8.3 MDx Health Prostate Cancer Diagnostics Introduction
11.8.4 MDx Health Revenue in Prostate Cancer Diagnostics Business (2018-2023)
11.8.5 MDx Health Recent Development
11.9 DiaSorin
11.9.1 DiaSorin Company Detail
11.9.2 DiaSorin Business Overview
11.9.3 DiaSorin Prostate Cancer Diagnostics Introduction
11.9.4 DiaSorin Revenue in Prostate Cancer Diagnostics Business (2018-2023)
11.9.5 DiaSorin Recent Development
11.10 Myriad Genetics
11.10.1 Myriad Genetics Company Detail
11.10.2 Myriad Genetics Business Overview
11.10.3 Myriad Genetics Prostate Cancer Diagnostics Introduction
11.10.4 Myriad Genetics Revenue in Prostate Cancer Diagnostics Business (2018-2023)
11.10.5 Myriad Genetics Recent Development
11.11 Ambry Genetics
11.11.1 Ambry Genetics Company Detail
11.11.2 Ambry Genetics Business Overview
11.11.3 Ambry Genetics Prostate Cancer Diagnostics Introduction
11.11.4 Ambry Genetics Revenue in Prostate Cancer Diagnostics Business (2018-2023)
11.11.5 Ambry Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Prostate Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Tumor Biomarker Tests
Table 3. Key Players of Imaging
Table 4. Key Players of Biopsy
Table 5. Key Players of Other
Table 6. Global Prostate Cancer Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Prostate Cancer Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Prostate Cancer Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Prostate Cancer Diagnostics Market Share by Region (2018-2023)
Table 10. Global Prostate Cancer Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Prostate Cancer Diagnostics Market Share by Region (2024-2029)
Table 12. Prostate Cancer Diagnostics Market Trends
Table 13. Prostate Cancer Diagnostics Market Drivers
Table 14. Prostate Cancer Diagnostics Market Challenges
Table 15. Prostate Cancer Diagnostics Market Restraints
Table 16. Global Prostate Cancer Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Prostate Cancer Diagnostics Market Share by Players (2018-2023)
Table 18. Global Top Prostate Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics as of 2022)
Table 19. Ranking of Global Top Prostate Cancer Diagnostics Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Prostate Cancer Diagnostics Product Solution and Service
Table 23. Date of Enter into Prostate Cancer Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prostate Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2018-2023)
Table 27. Global Prostate Cancer Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2024-2029)
Table 29. Global Prostate Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2018-2023)
Table 31. Global Prostate Cancer Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2024-2029)
Table 33. North America Prostate Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Prostate Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Prostate Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Prostate Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Prostate Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Prostate Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Prostate Cancer Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Prostate Cancer Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Prostate Cancer Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Prostate Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Prostate Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Prostate Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Prostate Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 48. OPKO Company Detail
Table 49. OPKO Business Overview
Table 50. OPKO Prostate Cancer Diagnostics Product
Table 51. OPKO Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 52. OPKO Recent Development
Table 53. Genomic Health Company Detail
Table 54. Genomic Health Business Overview
Table 55. Genomic Health Prostate Cancer Diagnostics Product
Table 56. Genomic Health Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 57. Genomic Health Recent Development
Table 58. Abbott Company Detail
Table 59. Abbott Business Overview
Table 60. Abbott Prostate Cancer Diagnostics Product
Table 61. Abbott Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 62. Abbott Recent Development
Table 63. Beckman Coulter Company Detail
Table 64. Beckman Coulter Business Overview
Table 65. Beckman Coulter Prostate Cancer Diagnostics Product
Table 66. Beckman Coulter Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 67. Beckman Coulter Recent Development
Table 68. Siemens Healthcare Company Detail
Table 69. Siemens Healthcare Business Overview
Table 70. Siemens Healthcare Prostate Cancer Diagnostics Product
Table 71. Siemens Healthcare Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 72. Siemens Healthcare Recent Development
Table 73. bioMeriux Company Detail
Table 74. bioMeriux Business Overview
Table 75. bioMeriux Prostate Cancer Diagnostics Product
Table 76. bioMeriux Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 77. bioMeriux Recent Development
Table 78. Roche Company Detail
Table 79. Roche Business Overview
Table 80. Roche Prostate Cancer Diagnostics Product
Table 81. Roche Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 82. Roche Recent Development
Table 83. MDx Health Company Detail
Table 84. MDx Health Business Overview
Table 85. MDx Health Prostate Cancer Diagnostics Product
Table 86. MDx Health Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 87. MDx Health Recent Development
Table 88. DiaSorin Company Detail
Table 89. DiaSorin Business Overview
Table 90. DiaSorin Prostate Cancer Diagnostics Product
Table 91. DiaSorin Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 92. DiaSorin Recent Development
Table 93. Myriad Genetics Company Detail
Table 94. Myriad Genetics Business Overview
Table 95. Myriad Genetics Prostate Cancer Diagnostics Product
Table 96. Myriad Genetics Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 97. Myriad Genetics Recent Development
Table 98. Ambry Genetics Company Detail
Table 99. Ambry Genetics Business Overview
Table 100. Ambry Genetics Prostate Cancer Diagnostics Product
Table 101. Ambry Genetics Revenue in Prostate Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 102. Ambry Genetics Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Diagnostics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Prostate Cancer Diagnostics Market Share by Type: 2022 VS 2029
Figure 3. Tumor Biomarker Tests Features
Figure 4. Imaging Features
Figure 5. Biopsy Features
Figure 6. Other Features
Figure 7. Global Prostate Cancer Diagnostics Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Prostate Cancer Diagnostics Market Share by Application: 2022 VS 2029
Figure 9. Age Below 55 Case Studies
Figure 10. Age 55-75 Case Studies
Figure 11. Age Above 75 Case Studies
Figure 12. Prostate Cancer Diagnostics Report Years Considered
Figure 13. Global Prostate Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Prostate Cancer Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Prostate Cancer Diagnostics Market Share by Region: 2022 VS 2029
Figure 16. Global Prostate Cancer Diagnostics Market Share by Players in 2022
Figure 17. Global Top Prostate Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics Revenue in 2022
Figure 19. North America Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Prostate Cancer Diagnostics Market Share by Country (2018-2029)
Figure 21. United States Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Prostate Cancer Diagnostics Market Share by Country (2018-2029)
Figure 25. Germany Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Prostate Cancer Diagnostics Market Share by Region (2018-2029)
Figure 33. China Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Prostate Cancer Diagnostics Market Share by Country (2018-2029)
Figure 41. Mexico Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Prostate Cancer Diagnostics Market Share by Country (2018-2029)
Figure 45. Turkey Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Prostate Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. OPKO Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 48. Genomic Health Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 49. Abbott Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 50. Beckman Coulter Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 51. Siemens Healthcare Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 52. bioMeriux Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 53. Roche Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 54. MDx Health Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 55. DiaSorin Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 56. Myriad Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 57. Ambry Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
  • Global HPV Testing Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 21-Mar-2023        Price: US 3260 Onwards        Pages: 102
    The HPV Testing market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the HPV Testing industry, and breaks down according to the type, application, and consumption area of HPV Testing. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.......
  • 2023 World Tumor Marker Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--A 92-Country Analysis--Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
    Published: 16-Mar-2023        Price: US 28500 Onwards        Pages: 0
    This new 92-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.The report is available by section, and can be customized to specific information needs and budget. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective b......
  • 2023 Asia-Pacific Tumor Markers Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--An 18-Country Analysis--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
    Published: 16-Mar-2023        Price: US 14500 Onwards        Pages: 0
    The report is available in Local PDF, Global PDF, and Data Pack formats (supplier shares, test volumes, sales forecasts). The report is delivered in both Excel and PDF.This new 18-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.The report is available by section, and can be customized to specific information needs and budget. This report is designed to assist diagnostics industry executives, as well as c......
  • 2023 Europe Tumor Markers Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--A 38-Country Analysis--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
    Published: 16-Mar-2023        Price: US 19500 Onwards        Pages: 0
    This new 38-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.The report is available by section, and can be customized to specific information needs and budget. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business......
  • 2023 Latin America Tumor Markers Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--A 22-Country Analysis--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
    Published: 16-Mar-2023        Price: US 14500 Onwards        Pages: 0
    The report is available in Local PDF, Global PDF, and Data Pack formats (supplier shares, test volumes, sales forecasts). The report is delivered in both Excel and PDF.This new 22-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.The report is available by section, and can be customized to specific information needs and budget. This report is designed to assist diagnostics industry executives, as well as ......
  • 2023 Middle East Tumor Markers Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--An 11-Country Analysis--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
    Published: 16-Mar-2023        Price: US 8500 Onwards        Pages: 0
    This new 11-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.The report is available by section, and can be customized to specific information needs and budget. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business......
  • 2023 North America Tumor Markers Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--US, Canada, Mexico--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
    Published: 16-Mar-2023        Price: US 8500 Onwards        Pages: 0
    This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.The report is available by section, and can be customized to specific information needs and budget. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business s......
  • 2023 Global Tumor Markers Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--US, Europe, Japan--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
    Published: 16-Mar-2023        Price: US 19500 Onwards        Pages: 0
    LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years.The report is available by section, and can be customized to specific information needs and budget.The report examines trends in the U.S., Europe and Japan; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market se......
  • 2023 Europe Tumor Markers Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--France, Germany, Italy, Spain, UK--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
    Published: 16-Mar-2023        Price: US 14500 Onwards        Pages: 0
    LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the European cancer diagnostics market during the next five years.The report is available by section, and can be customized to specific information needs and budget.The report examines trends in major European countries; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market se......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs